Mutations preferentially found in T cell-inflamed tumors included TP53 (breast cancer), PIK3CA (stomach), BRAF (thyroid), and VHL (kidney renal clear cell carcinoma) (Fig. 1b, left panel). The gene discussed is VHL; the disease is breast carcinoma.